Pacira ($PCRX) announced an update on their ongoing clinical study. Study Overview: Pacira Pharmaceuticals is running a Phase 2 trial titled “A ...

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has shared an announcement. Paradigm Biopharmaceuticals has confirmed it has enrolled or randomised ...

SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic ...

Osteoarthritis (OA) remains one of the leading causes of disability worldwide, burdening health systems and diminishing quality of life ...

Patients with OA who received a TKA were associated with a higher risk of developing new-onset OSA and insomnia compared with control individuals.

Rutgers Health experts have expanded treatment options for knee osteoarthritis, a condition caused by the gradual breakdown ...

The PPV-06 vaccine was safe, immunogenic, and linked with functional improvement at 42 weeks in a phase 1 trial of inflammatory knee osteoarthritis.

Transcutaneous auricular vagus nerve stimulation demonstrates safety and potential benefits in patients with erosive hand ...

A generic product for managing pain and inflammation associated with osteoarthritis (OA) in canines has been approved by FDA ...

Knee osteoarthritis pain can be eased without surgery or medication. Researchers are exploring gait training, a method to ...

Most people with knee osteoarthritis can control their pain and improve their mobility without surgery, according to updated treatment guidelines from the Australian Commission on Safety and Quality ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 TRIUMPH-4 clinical trial ...